Skip to main content
. 2016 Oct 18;7:13132. doi: 10.1038/ncomms13132

Figure 6. Improvement of mammalian AP conduction by BacNav in modeled pathological conditions.

Figure 6

(a) Schematic depicting direct expression of BacNav in mammalian excitable tissues containing endogenous Nav1.5, to enhance conduction and prevent conduction block in simulated pathological conditions. (b) Steady-state inactivation (h) of NavSheP D60A is more depolarized compared with that of Nav1.5 (n=5). (c,d) Conduction failure due to inactivation of Nav1.5 by membrane depolarization with elevated extracellular K+ (c, n=6) or blocking of intercellular coupling by PA (d, n=12–18) in Ex293 monolayers (black squares) is rescued by co-expression of NavSheP D60A (white circles). (e) Schematic depicting exogenous expression of BacNav in neonatal rat CMs to increase resistance to conduction block in ischaemic conditions. Black dashed circle denotes position of glass coverslip used to induce regional ischaemia in CM monolayer. (f) Progressive conduction slowing until block with time of ischaemia in control (CM) and NavSheP D60A transduced (CM+D60A) monolayers (n=6). (g,h) Representative isochrones maps of a CM monolayer showing conduction slowing after 6 min (g) and complete block after 11 min of ischaemia (h). Pulse signs indicate location of stimulating electrode. Circles denote 504 recording sites. (i) Under ischaemic condition, CMs transduced with NavSheP D60A lentivirus (white) resisted conduction block longer than control CMs (black) (n=6, #P<0.01). Error bars indicate s.e.m; statistical significance was determined by an unpaired Student's t-test to calculate P-value.